CDH1 and breast carcinoma: The expression of this molecule has been correlated in breast cancer with recurrence, poor survival and malignancy, as well as decreased expression of E-cadherin and increased expression of vimentin as well as by the expression of β-catenin at the nuclear level that stimulates cell migration33,48,50.